AtriCure, Inc.
ATRC
$29.81
$0.280.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.88% | 15.80% | 16.28% | 15.79% | 16.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.88% | 15.80% | 16.28% | 15.79% | 16.55% |
| Cost of Revenue | 13.56% | 15.41% | 16.89% | 18.15% | 19.12% |
| Gross Profit | 15.32% | 15.94% | 16.07% | 15.02% | 15.70% |
| SG&A Expenses | 6.75% | 6.27% | 8.95% | 11.00% | 14.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.65% | 13.09% | 14.89% | 15.28% | 18.53% |
| Operating Income | 76.39% | 22.53% | 2.20% | -8.75% | -47.68% |
| Income Before Tax | 76.73% | 26.37% | 10.17% | -1.54% | -46.33% |
| Income Tax Expenses | 25.49% | -16.27% | 27.10% | 55.17% | 73.27% |
| Earnings from Continuing Operations | 74.39% | 26.07% | 9.38% | -2.54% | -46.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.39% | 26.07% | 9.38% | -2.54% | -46.85% |
| EBIT | 76.39% | 22.53% | 2.20% | -8.75% | -47.68% |
| EBITDA | 152.09% | 61.36% | 19.96% | 1.40% | -73.26% |
| EPS Basic | 74.67% | 26.93% | 10.62% | -1.21% | -44.87% |
| Normalized Basic EPS | 76.23% | 24.49% | 8.23% | -2.86% | -37.93% |
| EPS Diluted | 74.60% | 26.93% | 10.62% | -1.21% | -44.87% |
| Normalized Diluted EPS | 76.12% | 24.49% | 8.23% | -2.86% | -37.93% |
| Average Basic Shares Outstanding | 1.67% | 1.59% | 1.53% | 1.45% | 1.42% |
| Average Diluted Shares Outstanding | 2.16% | 1.59% | 1.53% | 1.45% | 1.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |